Curosurf

Product manufactured by Chiesi Usa, Inc.

Application Nr Approved Date Route Status External Links
BLA020744 None Endotracheal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Curosurf ® (Poractant Alfa) Intratracheal Suspension Is Indicated For The Rescue Treatment Of Respiratory Distress Syndrome (Rds) In Premature Infants. Curosurf Reduces Mortality And Pneumothoraces Associated With Rds. Curosurf Is A Surfactant Indicated For The Rescue Treatment, Including The Reduction Of Mortality And Pneumothoraces, Of Respiratory Distress Syndrome (Rds) In Premature Infants. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Poractant Alfa

Comments